Good results shame there are no CR’s. I’d like to see them skip to Efti ketruda and chemo in a reg trial. That’s where the most good will be done.
But the pace this thing moves that won’t happen until the patents have run out.
The patent runways aren’t long enough anymore in oncology.
Also, with general health and improvement in existing SoC it’s difficult to know if a OS improvement is a result of the drug. Efti would do a lot better if it achieved CR’s but they are few and far between.
- Forums
- ASX - By Stock
- Ann: Excellent initial Overall Survival Benefit in 1st line NSCLC
Good results shame there are no CR’s. I’d like to see them skip...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
37.0¢ |
Change
0.010(2.78%) |
Mkt cap ! $537.4M |
Open | High | Low | Value | Volume |
36.0¢ | 37.0¢ | 36.0¢ | $563.7K | 1.544M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 386559 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 261422 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 228 | 0.380 |
3 | 4323 | 0.370 |
1 | 42156 | 0.365 |
7 | 222514 | 0.360 |
6 | 102499 | 0.355 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 218616 | 10 |
0.375 | 184000 | 6 |
0.380 | 118909 | 8 |
0.385 | 82622 | 5 |
0.390 | 182494 | 4 |
Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online